Giampaolo Talamo
Overview
Explore the profile of Giampaolo Talamo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Malysz J, Talamo G, Zhu J, Clarke L, Bayerl M, Ali L, et al.
J Am Acad Dermatol
. 2016 Feb;
74(5):878-84.
PMID: 26874821
Background: Disease-specific skin lesions are rare in patients with multiple myeloma (MM). Objective: We sought to further characterize the clinical and pathologic features of patients with cutaneous involvement with MM....
12.
Wang W, Cheng J, Mallon C, Al-Marrawi M, Holder S, Joshi M, et al.
Clin Genitourin Cancer
. 2015 Aug;
13(6):e391-5.
PMID: 26303589
No abstract available.
13.
Talamo G, Mir Muhammad A, Pandey M, Zhu J, Creer M, Malysz J
Rare Tumors
. 2015 Apr;
7(1):5686.
PMID: 25918613
Measurement of daily proteinuria in patients with amyloidosis is recommended at the time of diagnosis for assessing renal involvement, and for monitoring disease activity. Renal involvement is usually defined by...
14.
Patel U, Mir M, Sivik J, Raheja D, Pandey M, Talamo G
Hematol Rep
. 2015 Apr;
7(1):5704.
PMID: 25852850
Immunomodulatory drugs (IMiDs) currently used in the treatment of multiple myeloma, are thalidomide, lenalidomide and pomalidomide. One of the most common side effects of thalidomide is neurotoxicity, predominantly in the...
15.
Wyluda E, Cheng J, Schell T, Haley J, Mallon C, Neves R, et al.
Cancer Biol Ther
. 2015 Mar;
16(5):662-70.
PMID: 25806780
We report 3 cases of durable complete response (CR) in patients with BRAF-mutated metastatic melanoma who were initially treated unsuccessfully with sequential immunotherapies (high dose interleukin 2 followed by ipilimumab...
16.
Talamo G, DiMaio C, Abbi K, Pandey M, Malysz J, Creer M, et al.
Front Oncol
. 2015 Mar;
5:40.
PMID: 25741475
Background: Radiation therapy (RT) is a treatment modality traditionally used in patients with multiple myeloma (MM), but little is known regarding the role and effectiveness of RT in the era...
17.
Talamo G, Mir M, Pandey M, Sivik J, Raheja D
Ann Hematol
. 2015 Jan;
94(6):1011-6.
PMID: 25572169
Anti-MAG neuropathy is a very rare form of acquired polyneuropathy associated with IgM monoclonal gammopathy of undetermined significance (MGUS). We conducted a retrospective review of 194 consecutive MGUS patients seen...
18.
Al-Marrawi M, Cream L, Mallon C, Holder S, Joshi M, Harvey H, et al.
J Clin Oncol
. 2015 Jan;
33(5):521-2.
PMID: 25559812
No abstract available.
19.
Talamo G, Sivik J, Pandey M, Mir M
J Oncol Pharm Pract
. 2014 Dec;
22(2):332-4.
PMID: 25516544
Acute pancreatitis is a rare complication of chemotherapy agents. We describe the case of a patient with multiple myeloma who developed acute pancreatitis after treatment with bortezomib, a proteasome inhibitor...
20.
Cheng J, Talamo G, Malysz J, Ochmann M, Lamy T, Loughran Jr T
Clin Lymphoma Myeloma Leuk
. 2014 Jul;
14(5):e169-72.
PMID: 25037886
No abstract available.